Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
4
×
national top stories
startups
4
×
biotech
boston blog main
cancer
deals
detroit blog main
detroit top stories
europe blog main
europe top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
astrazeneca
boston top stories
boulder/denver blog main
boulder/denver top stories
covid-19
financing
funding
gilead sciences
healthcare
indiana blog main
indiana top stories
innovation
national
What
sciences
4
×
acquisitions
bio
ceo
daniel
gilead
life
o’day
roundup
years
admits
ago
amsterdam
announced
big
biggest
biotechs
board
bristol
build
buy
classes
collabs
combinator
companies
company’s
covid
deal
debut
drug
dug
dyne’s
european
firm
focused
fund
gilead’s
healthcare
help
incubator
Language
unset
4
×
Current search:
unset
×
startups
×
" national blog main "
×
sciences
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
With Bristol and Otsuka on Board, LSP Raises $620M EU Life Sciences Fund
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In